Ph.D. Michael Exton - 08 Jul 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael Exton, Ph.D.
Issuer symbol
LXRX
Transactions as of
08 Jul 2024
Net transactions value
$0
Form type
4
Filing time
08 Jul 2024, 17:27:00 UTC
Next filing
18 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +1,675,000 $0.000000 1,675,000 08 Jul 2024 Common Stock 1,675,000 $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.